Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Journal: AIDS and behavior

Publication date: 2018

Journal: AIDS and behavior

Publication Year: 2018

Authors & Co-authors:  Carballo-Diéguez Alex A Giguere Rebecca R Dolezal Curtis C Leu Cheng-Shiun CS Balán Iván C IC Brown William W Rael Christine C Richardson Barbra A BA Piper Jeanna M JM Bekker Linda-Gail LG

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Chinula Ziemba Brummel McCarthy Coletti Krotje Johnston Knowles Moyo Stranix-Chibanda

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Journal: Lancet (London, England)

Publication date: 2022

Journal: Lancet (London, England)

Publication Year: 2022

Authors & Co-authors:  Delany-Moretlwe Hughes Bock Ouma Hunidzarira Kalonji Kayange Makhema Mandima Mathew